Activation of protein kinase C subtypes α, γ, δ, ε, ζ, and η by tumor-promoting and nontumor-promoting agents

Biochemical Pharmacology

Volumn 53, Issue 6, 1997, Pages 865-875

  Geiges, Detlef ^b   Meyer, Thomas ^a   Marte, Barbara ^a   Vanek, Mirka ^a   Weissgerber, Georges ^a   Stabel, Silvia ^c   Pfeilschifter, Josef ^d   Fabbro, Doriano ^a   Huwiler, Andrea ^d  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Max Delbruck Laboratorium der Max Planck Gesellschaft   (Germany)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

bryostatin 1; indolactam V; mezerein; protein kinase C; sapintoxin D; tumor promoters

Indexed keywords

BRYOSTATIN 1; INDOLACTAM V; ISOENZYME; K 252A; MEZEREIN; MIDOSTAURIN; PHORBOL ESTER; PROTEIN KINASE C; RECOMBINANT PROTEIN; RESINIFERATOXIN; SAPINTOXIN D; STAUROSPORINE; THAPSIGARGIN; TINYATOXIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SPECIFICITY; GENE EXPRESSION; INSECT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION;

ANIMALS; CARCINOGENS; ENZYME ACTIVATION; ISOENZYMES; PHOSPHORYLATION; PROTEIN KINASE C; SPODOPTERA; STAUROSPORINE; SUBSTRATE SPECIFICITY;

EID: 0030949418     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00885-4     Document Type: Article

References (53)

1. Stabel S and Parker PJ, Protein kinase C. Pharmacol Ther 51: 71-95, 1991.
2. Hug H and Sarre TF, Protein kinase C isoenzymes: Divergence in signal transduction? Biochem J 291: 329-343, 1993.
3. Johannes F-J, Prestle J, Eis S, Oberhagemann P and Pfizenmaier K, PKCμ, is a novel, atypical member of the protein kinase C family. J Biol Chem 269: 6140-6148, 1994.
4. Selbie LA, Schmitz-Pfeiffer C, Sheng Y and Biden TJ, Molecular cloning and characterization of PKC, an atypical isoform of protein kinase C derived from insulin-secreting cells. J Biol Chem 268: 24296-24302, 1993.
5. Akimoto K, Mizuno K, Osada S-i, Hirai S-i, Tanuma S-i, Suzuki K and Ohno S, A new member of the third class in the protein kinase C family, PKC λ, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J Biol Chem 269: 12677-12683, 1994.
6. Borner C and Fabbro D, PKC and cellular transformation. In: Protein Kinase C: Current Concepts and Future Perspectives (Eds. Lester D and Epand R), pp. 297-354. Ellis Horwood Series in Biochemistry and Biotechnology, Chichester, 1992.
7. Huwiler A, Fabbro D and Pfeilschifter J, Possible regulatory functions of protein kinase C-α and -ε isoenzymes in rat renal mesangial cells. Biochem J 279: 441-445, 1991.
8. Crabos M, Fabbro D, Stabel S and Erne P, Effect of tumourpromoting phorbol ester, thrombin and vasopressin on translocation of three distinct protein kinase C isoforms in human platelets and regulation by calcium. Biochem J 288: 891-896, 1992.
9. Nishizuka Y, Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-613, 1992.
10. Hecker E, Cell membrane associated protein kinase C as receptor of diterpene ester co-carcinogens of the tumor promoter type and the phenotypic expression of tumors. Arzneimforsch/Drug Res 35: 1890-1903, 1985.
11. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U and Nishizuka Y, Direct activation of calcium-activated, phospho-lipid-dependent protein kinase by tumour-promoting phorbol esters. J Biol Chem 257: 7847-7851, 1982.
12. 125I]EGF binding and stimulate the phosphorylation of an 80 kd protein kinase C substrate protein in intact quiescent Swiss 3T3 cells. Carcinogenesis 11: 667-672, 1990.
13. Schmidt RJ and Evans FJ, Investigations into the skin-irritant properties of resiniferonol ortho esters. Inflammation 3: 273-280, 1979.
14. Szallasi A, Sharkey N and Blumberg PM, Structure-activity analysis of resiniferatoxin analogs. Phytother Res 3: 253-257, 1989.
15. Fujiki H, Saganuma M, Nakayasu M, Tahira T, Endo Y, Shudo K and Sugimura T, Structure-activity studies on synthetic analogues (indolactams) of the tumor promoter teleocidin. Gann 75: 866-870, 1984.
16. Berkow RL and Kraft AS, Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor. Biochem Biophys Res Commun 131: 1109-1116, 1985.
17. Gschwendt M, Fürstenberger G, Rose-John S, Rogers M, Kittstein W, Pettit GR, Herald CL and Marks F, Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro. Carcinogenesis 9: 555-562, 1988.
18. Hakii H, Fujiki H, Suganuma M, Nakayusa M, Tahira T, Sugimura T, Scheuer PJ and Christensen SB, Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol III: 177-181, 1986.
19. Ryves WJ, Evans AT, Olivier AR, Parker PJ and Evans FJ, Activation of the PKC-isotypes α, βl, γ, δ and ε by phorbol esters of different biological activities. FEBS Lett 288: 5-9, 1991.
20. Kazanietz MG, Areces LB, Bahador A, Mischak H, Goodnight J, Mushinski JF and Blumberg PM, Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. Mol Pharmacol 44: 298-307, 1993.
21. Huwiler A, Fabbro D and Pfeilschifter J, Comparison of different tumor promoters and bryostatin 1 on protein kinase C activation and down-regulation in rat renal mesangial cells. Biochem Pharmacol 48: 689-700, 1994.
22. Stabel S, Schaap D and Parker PJ, Expression of protein kinase C isotypes using baculovirus vectors. Methods Enzymol 200: 670-673, 1992.
23. Liyanage M, Frith D, Livneh E and Stabel S, Protein kinase C group members PKC-δ, -ε, ζ and PKC-L (η): Comparison of properties of recombinant proteins in vitro and in vivo. Biochem J 283: 781-787, 1992.
24. McGlynn E, Liebetanz J, Reutener S, Wood J, Lydon NB, Hofstetter H, Vanek M, Meyer T and Fabbro D, Expression and partial characterization of rat protein kinase C-δ and protein kinase C-ζ in insect cells using recombinant baculovirus. J Cell Biochem 49: 239-250, 1992.
25. Osada S-i, Mizuno K, Saido TC, Akita Y, Suzuki K, Kuroki T and Ohno S, A phorbol ester receptor/protein kinase, nPKCη, a new member of the protein kinase C family predominantly expressed in lung and skin. J Biol Chem 265: 22434-22440, 1990.
26. Gruenwald S and Heitz J, Baculovirus Expression Vector Systems: Procedures & Methods Manual, 2nd ed. PharMingen, San Diego, CA, 1993.
27. Summers MD and Smith GE, A Manual Methods for Baculovirus Vectors and Insect Cells Culture Procedure. Texas Agricultural Station Bulletin No. 1555, 1987.
28. Borner C, Filipuzzi I, Wartmann M, Eppenberger U and Fabbro D, Biosynthesis and posttranslational modifications of protein kinase C in human breast cancer cells. J Biol Chem 264: 13902-13909, 1989.
29. Fabbro D, Küng W, Roos W, Regazzi R and Eppenberger U, Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: Possible quantitative relationship. Cancer Res 46: 2720-2725, 1986.
30. Marte BM, Meyer T, Stabel S, Jaken S, Fabbro D and Hynes NE, Protein kinase C and mammary cell differentiation: Involvement of PKC-α in the induction of β-casein expression. Cell Growth Diff 5: 239-247, 1994.
31. Nakanishi H and Exton JH, Purification and characterization of the ζ isoform of protein kinase C from bovine kidney. J Biol Chem 267: 16347-16354, 1992.
32. Kazanietz MG, Bustelo XR, Barbacid M, Kolch W, Mischak H, Wong G, Pettit GR, Bruns JD and Blumberg PM, Zinc finger domains and phorbol ester pharmacophore. J Biol Chem 269: 11590-11594, 1994.
33. Cazaubon S, Webster C, Camoin L, Strosberg AD and Parker PJ, Effector-dependent conformational changes in protein kinase Cγ through epitope mapping with inhibitory monoclonal antibodies. Eur J Biochem 194: 799-804, 1990.
34. Burns DJ and Bell RM, Protein kinase C contains two phorbol ester binding domains. J Biol Chem 266: 18330-18338, 1991.
35. Schaap D and Parker PJ, Expression, purification, and characterization of protein kinase C-ε. J Biol Chem 265: 7301-7307, 1990.
36. Huwiler A, Fabbro D, Stabel S and Pfeilschifter J, Immuno-characterization of δ-and ζ-isoenzymes of protein kinase C in rat renal mesangial cells. FEES Lett 300: 259-262, 1992.
37. 2+-dependent protein kinase. Biochem Biophys Res Commun 135: 397-402, 1986.
38. Meyer T, Regenass U, Fabbro D, Alteri E, Rösel J, Müller M, Caravatti G and Matter A, A derivative of Staurosporine (CGP 41251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity. Int J Cancer 43: 851-856, 1989.
39. Kase H, Iwahashi K and Matsuda Y, K252a, a potent inhibitor of protein kinase C from microbial origin. J Antibiot 39: 1059-1063, 1986.
40. Aris JP, Basts PV, Holmes WD, Ballas LM, Moomaw C, Rankl NB, Blobel G, Loomis CR and Burns DJ, Molecular and biochemical characterization of a recombinant human PKC-δ family member. Biochim Biophys Acta 1174: 171-181, 1993.
41. 11protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells. J Biol Chem 266: 28-33, 1991.
42. Szallasi Z, Smith CB, Pettit GR and Blumberg PM, Differen-tial regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J Biol Chem 269: 2118-2124, 1994.
43. Kazanietz MG, Krausz KW and Blumberg PM, Differential irreversible insertion of protein kinase C into phospholipid vesicles by phorbol esters and related activators. J Biol Chem 267: 20878-20886, 1992.
44. 2+-ATPase. Proc Natl Acad Sci USA 87: 2464-2470, 1990.
45. Kiley SC, Parker PJ, Fabbro D and Jaken S, Selective redistribution of protein kinase C isozymes by thapsigargin and staurosporine. Carcinogenesis 13: 1997-2001, 1992.
46. Mizuno K, Saido TC, Ohno S, Tamaoki T and Suzuki K, Staurosporine-related compounds, K252a and UCN-01, inhibit both cPKC and nPKC. FEES Lett 330: 114-116, 1993.
47. Pfeilschifter J and Huwiler A, A role for protein kinase-ε in angiotensin II stimulation of phospholipase D in rat renal mesangial cells. FEBS Lett 331: 267-271, 1993.
48. Huwiler A and Pfeilschifter J, Stimulation by extracellular ATP and UTP of the mitogen-activated protein kinase cas-cade and proliferation of rat renal mesangial cells. Br J Pharmacol 113: 1455-1463, 1994.
49. Mühl H and Pfeilschifter J, Possible role of protein kinase C-ε. isoenzyme in inhibition of interleukin 1β induction of nitric oxide synthase in rat renal mesangial cells. Biochem J 303: 607-612, 1994.
50. Huwiler A and Pfeilschifter J, A role for protein kinase C-α in zymosan-stimulated eicosanoid synthesis in mouse peritoneal macrophages. Eur J Biochem 217: 69-75, 1993.
51. Mischak H, Goodnight J, Kolch W, Martiny-Baron G, Schaechtele C, Kazanietz GM, Blumberg PM, Pierce JH and Mushinski JF, Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage-dependence and tumorigenicity. J Biol Chem 268: 6090-6096, 1993.
52. Berra E, Diaz-Meco MT, Dominguez I, Municio MM, Sanz L, Lozano J, Chapkin RS and Moscat J, PKC ζ isoform is critical for mitogenic signal transduction. Cell 74: 555-563, 1993.
53. 2+-independent isoform of protein kinase C in epithelial tissues, in association with epithelial differentiation. Cell Growth Diff 4: 167-175, 1993.